SlideShare a Scribd company logo
Competition between providers:
Solution, problem, or both?
(necessity or nicety?)

Dr Jennifer Dixon
Director
The Nuffield Trust


                     24 March 2010
Structure

  Framework
  Hospital care
    – Independent sector activity
    – Choice
    – Impact
  Primary and community care
  Regulation
  Where next?



                                    2
Framework: a lever to improve performance
                       Target, directive, guidance
Some levers to improve quality

                           Commissioner
                             Provider

                                Q
      Local                                          Regulation
      accountability            E




                            Financial
                            incentives
Framework: some key policies


   Introduction of market-like mechanisms in NHS
      – 2002: independent sector clinical care encouraged
      – 2004: First FTs
      – 2003/4: payment by results (FTs)
      – 2004/5: payment by results (all providers)
      – 2006: patient choice of 4-5 providers
      – 2007: NHS Choices website


                                                   4
Regulatory framework

 CCP : advises on cases arising under the Principles and
  Rules covering:
        mergers between providers of NHS services – the
          basis on which these should be allowed
        the conduct of commissioners and service
          providers when it impacts on patient choice,
          cooperation and competition
        the procurement of services by commissioners
        advertising by service providers


                                                  5
Independent sector activity



    Hospital care




                              6
Number of NHS-funded inpatient episodes in independent-
sector healthcare providers by the month in which the episode
began




Source: Nuffield Trust
Volumes of NHS-funded activity in independent
  sector healthcare providers (HES)


                                      2004/5          2005/6          2006/7          2007/8
Number of inpatient episodes in                 18              26              74             103
independent sector providers (000s)
as percentage of all episodes                  0.1%            0.2%            0.5%            0.6%
Number of outpatient attendances at              18              54                             268
independent sector providers (000s)
as percentage of all attendances               0.0%            0.1%                            0.4%




  Source: Nuffield Trust
Source: Departmental Report 2008/9
Inpatient activity of ISTCs in England
    (2007/8)
                                      Location of ISTC
                                      (volume indicates
                                      number of inpatient
                                      episodes)

                                      ISTC not reporting in
                                      HES




                                             10
Source: Hospital Episode Statistics
Use of the independent sector is limited
(2007/8)
                The independent
                sector supplies 1%+
                of inpatient episodes
                for 17% of practices
                                    The independent
                                    sector supplies 5%+
                                    of inpatient episodes
                                    for just 2% of
                                    practices
Practices using the independent sector the most (2007/8)



                                  General practice
                                  using the independent
                                  sector for 5%+ of
                                  inpatient episodes
The utilisation of ISTCs and their location (2007/8)
                                   Location of ISTC
                                   (volume indicates
                                   number of inpatient
                                   episodes)

                                   ISTC not reporting in
                                   HES




                                   General practice
                                   using the independent
                                   sector for 5%+ of
                                   inpatient episodes
Practices using the independent sector the most (2007/8)

5%+ of outpatient attendance   5%+ of inpatient episodes




                                       Source: Hospital Episode Statistics
Summary of progress
  The majority of practices in England (60%) had some
   independent sector provided care in 2007/8, the amounts
   are typically very small.
  Nationally, at most 1% volume of NHS-funded acute
   hospital care is provided for the independent sector, even
   allowing for the shortcomings of the available data in HES.
  NHS-funded independent sector provision of acute
   hospital care is relatively small and concentrated in few
   parts of the country.
Choice




         16
Choices offered to patients: number of choices and
    whether private sector option was offered




    Source: Robertson R, Dixon A. Choice at the point of referral. King’s Fund
Number of patients who were offered a choice and who
   attended the hospital they wanted




    Source: Robertson R, Dixon A. Choice at the point of referral. King’s Fund
Number (%) of patients who were offered a choice and
   who attended their local hospital




     Source: Robertson R, Dixon A. Choice at the point of referral. King’s Fund
Factors that influenced patients’ choice of hospital




         Source: Robertson R, Dixon A. Choice at the point of referral. King’s Fund
Impact




         21
1990 Reforms
   Existing evidence on effects of competition on health
    outcomes in UK (England) based on ‘internal market’ of
    the 1990s
   1990s reforms involved price competition, so incentives
    to drive costs down, not quality up
   Competition related to purchaser choice, not patient
    choice
   Propper et al (2004, 2008) find competition erodes quality
    using hospital trust data


    Source: Cooper Z.                                22
Health Select Committee Report 2005/6:
   ISTCs
  No great contribution to capacity
  Increased choice
  No information about quality
  Anecdotal impact on NHS providers from the threat of
   competition
  Good practice and innovation but ? Relative to NHS?
  Uncertainty about efficiency
  Concerns about training
Healthcare Commission report on quality
   of ISTCs

 July 2008 and 2009:
   – Patients rated experience highly
   – Poor quality coding of data
       Clinical quality cannot be assessed
Length of stay for inpatient spells ending
in 2007/8




 Source: Nuffield Trust
Death by market power?
Propper C, Gaynor M, Moreno-Serra C. 2010




Does hospital competition save lives?
Cooper Z, Gibbons S, Jones S, McGuire A. 2010
Increase in competition 2003/4 to 2007/8
    (actual provider HHI)




   Propper C, Gaynor M, Moreno-Serra C. 2010
Increase in competition around conurbations




   Propper C, Gaynor M, Moreno-Serra C. 2010
Impact of competition on outcomes and
   waiting times

   Death rates fell more in competitive areas (note
    not just AMI related deaths)
   Magnitude: a one standard deviation increase in
    competition leads to around 487 fewer AMI
    deaths = about 16% of mean fall 2003-2007
   No change in waits or other clinical measures of
    outcome


  Propper C, Gaynor M, Moreno-Serra C. 2010
Conclusions

   Conclude: policy saved lives and did not increase
    costs (exact mechanism unknown)
   Do not necessarily need large change in
    competition to bring about change
   Cannot necessarily pre-judge where competitive
    pressures will be felt
   Active merger programme would reduce
    competitive pressure ….


   Propper C, Gaynor M, Moreno-Serra C. 2010
95% variable GP radius 2002 and 2008
    (all procedures)




 Cooper Z, Gibbons S, Jones S, McGuire A. 2010
Measures of quality

  Emergency admissions for Acute Myocardial
   Infarction (AMI – “heart attack” ICD I21 I22)
  Indicator that patient died within 30 days
  30 day mortality ubiquitous in the literature as a
   litmus/canary test of health care quality
     – Highly correlated with other aspects of health
        care quality in hospitals
  General decline in death rates due to technology:
   e.g. angioplasty, clot-busters (and less smoking)
     – Scope for variable adoption of technology

                                                    32
   Cooper Z, Gibbons S, Jones S, McGuire A. 2010
Adjusted for
   Patient: age, gender, ethnicity, Charlson co-morbidity
    score, IMD income deprivation
   Procedure: day and month of admission, angioplasty,
    distance from GP to hospital attended
   Hospital: teaching, Foundation status, number of AMIs
    treated per year
   Hospital site dummies, Strategic Health Authority trends,
    GP fixed effects



                                                     33
    Cooper Z, Gibbons S, Jones S, McGuire A. 2010
Results


  Robust evidence of faster rate of decline in AMI mortality
   post-2006 for patients from high-competition areas
  One standard deviation (0.54) more competition implies
   about 0.3 percentage points lower probability of AMI
   death during 1st year of reform
  Further 0.3 percentage points for each year after 2006
  Results suggest no pre-policy difference in trends
   between high and low competition areas


                                                      34
    Cooper Z, Gibbons S, Jones S, McGuire A. 2010
Primary and community independent care




                                35
Progress                                        Fig: Primary and community care tenders per month 07-09
  • Competition in primary and
    community care mostly involves
    competitive tendering
      • some patient choice in GP services
        and in some community services

  • The number of primary and
    community care tenders has been
    gradually increasing

  • Many contracts have been won by                Fig: Primary and community care tenders by service

    the independent sector

  • Transforming community services




Source: Quarterly Market Analysis, Local Partnerships, 2009
Contracts awarded

  Contracts awarded in 2009




                                                              37
Source: Quarterly Market Analysis, Local Partnerships, 2009
Where next?
  Progress (but short term wobble)
  Emerging evidence on competition good re
   quality (hospital only)
  Prospect of mergers reducing competition
  Promise of vertical integration to reduce
   avoidable costs
  ? Competition between vertical providers or
   payer/providers?
  How best regulated?
  Evidence for public benefit test?
                                           38

More Related Content

What's hot

Medicare Part D Take Up and Changes in Out-of-Pocket Prescription 4.28.08
Medicare Part D Take Up and Changes in Out-of-Pocket Prescription 4.28.08Medicare Part D Take Up and Changes in Out-of-Pocket Prescription 4.28.08
Medicare Part D Take Up and Changes in Out-of-Pocket Prescription 4.28.08
Leonard Davis Institute of Health Economics
 
Wesat2203
Wesat2203Wesat2203
Wesat2203
Mohamed Rafique
 
EpiCept Corporation (EPCT)
EpiCept Corporation (EPCT)EpiCept Corporation (EPCT)
EpiCept Corporation (EPCT)
Brett_Johnson
 
Chronic Opioid Therapy
Chronic Opioid TherapyChronic Opioid Therapy
Chronic Opioid Therapy
Group Health Cooperative
 
Access to Orphan Drugs in the UK and Other European Countries
Access to Orphan Drugs in the UK and Other European CountriesAccess to Orphan Drugs in the UK and Other European Countries
Access to Orphan Drugs in the UK and Other European Countries
Office of Health Economics
 
Twillman preventing rx abuse
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
American Academy of Family Physicians
 
Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
CBA Consórcio Brasileiro de Acreditação
 
COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY...
COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY...COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY...
COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY...
Gustavo Kasparas
 
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
University of Michigan Injury Center
 
Use of the Oncology Beacon Module and Virtual Data Warehouse Data to Identify...
Use of the Oncology Beacon Module and Virtual Data Warehouse Data to Identify...Use of the Oncology Beacon Module and Virtual Data Warehouse Data to Identify...
Use of the Oncology Beacon Module and Virtual Data Warehouse Data to Identify...
HMO Research Network
 
Austria 1652011
Austria 1652011Austria 1652011
Austria 1652011
Sherif Kamal
 
Fight Colorectal Cancer Legislative & Regulatory 2013 Agenda
Fight Colorectal Cancer Legislative & Regulatory 2013 AgendaFight Colorectal Cancer Legislative & Regulatory 2013 Agenda
Fight Colorectal Cancer Legislative & Regulatory 2013 Agenda
Fight Colorectal Cancer
 
Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.
Paul Coelho, MD
 
Access to cancer medications in low and middle income countries 2013.03.27
Access to cancer medications in low and middle income countries 2013.03.27Access to cancer medications in low and middle income countries 2013.03.27
Access to cancer medications in low and middle income countries 2013.03.27
gilberto lopes
 
SSDI & Opioid Use
SSDI & Opioid UseSSDI & Opioid Use
SSDI & Opioid Use
Paul Coelho, MD
 
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIANaloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
University of Michigan Injury Center
 
Vital Signs Edition #4
Vital Signs   Edition #4Vital Signs   Edition #4
Vital Signs Edition #4
ScottJordan
 
SSI -final
SSI -finalSSI -final
SSI -final
Eric Cybulski
 
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHScOpioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
University of Michigan Injury Center
 

What's hot (19)

Medicare Part D Take Up and Changes in Out-of-Pocket Prescription 4.28.08
Medicare Part D Take Up and Changes in Out-of-Pocket Prescription 4.28.08Medicare Part D Take Up and Changes in Out-of-Pocket Prescription 4.28.08
Medicare Part D Take Up and Changes in Out-of-Pocket Prescription 4.28.08
 
Wesat2203
Wesat2203Wesat2203
Wesat2203
 
EpiCept Corporation (EPCT)
EpiCept Corporation (EPCT)EpiCept Corporation (EPCT)
EpiCept Corporation (EPCT)
 
Chronic Opioid Therapy
Chronic Opioid TherapyChronic Opioid Therapy
Chronic Opioid Therapy
 
Access to Orphan Drugs in the UK and Other European Countries
Access to Orphan Drugs in the UK and Other European CountriesAccess to Orphan Drugs in the UK and Other European Countries
Access to Orphan Drugs in the UK and Other European Countries
 
Twillman preventing rx abuse
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
 
Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
 
COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY...
COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY...COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY...
COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY...
 
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
 
Use of the Oncology Beacon Module and Virtual Data Warehouse Data to Identify...
Use of the Oncology Beacon Module and Virtual Data Warehouse Data to Identify...Use of the Oncology Beacon Module and Virtual Data Warehouse Data to Identify...
Use of the Oncology Beacon Module and Virtual Data Warehouse Data to Identify...
 
Austria 1652011
Austria 1652011Austria 1652011
Austria 1652011
 
Fight Colorectal Cancer Legislative & Regulatory 2013 Agenda
Fight Colorectal Cancer Legislative & Regulatory 2013 AgendaFight Colorectal Cancer Legislative & Regulatory 2013 Agenda
Fight Colorectal Cancer Legislative & Regulatory 2013 Agenda
 
Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.Patterns of opioid use and risk of opioid overdose.
Patterns of opioid use and risk of opioid overdose.
 
Access to cancer medications in low and middle income countries 2013.03.27
Access to cancer medications in low and middle income countries 2013.03.27Access to cancer medications in low and middle income countries 2013.03.27
Access to cancer medications in low and middle income countries 2013.03.27
 
SSDI & Opioid Use
SSDI & Opioid UseSSDI & Opioid Use
SSDI & Opioid Use
 
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIANaloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
 
Vital Signs Edition #4
Vital Signs   Edition #4Vital Signs   Edition #4
Vital Signs Edition #4
 
SSI -final
SSI -finalSSI -final
SSI -final
 
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHScOpioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
 

Viewers also liked

Dr Jennifer Dixon: Commissioning and integrated care
Dr Jennifer Dixon: Commissioning and integrated careDr Jennifer Dixon: Commissioning and integrated care
Dr Jennifer Dixon: Commissioning and integrated care
Nuffield Trust
 
Peter Smith: Allocating health care budgets to general practices
Peter Smith: Allocating health care budgets to general practicesPeter Smith: Allocating health care budgets to general practices
Peter Smith: Allocating health care budgets to general practices
Nuffield Trust
 
Sara Shaw: The Trafford integration story
Sara Shaw: The Trafford integration storySara Shaw: The Trafford integration story
Sara Shaw: The Trafford integration story
Nuffield Trust
 
Jo Ellins: Priority setting is everyone’s business
Jo Ellins: Priority setting is everyone’s businessJo Ellins: Priority setting is everyone’s business
Jo Ellins: Priority setting is everyone’s business
Nuffield Trust
 
Professor Enthoven: Integrated delivery systems
Professor Enthoven: Integrated delivery systemsProfessor Enthoven: Integrated delivery systems
Professor Enthoven: Integrated delivery systems
Nuffield Trust
 
Jennifer Dixon: Financially challenged
Jennifer Dixon: Financially challengedJennifer Dixon: Financially challenged
Jennifer Dixon: Financially challenged
Nuffield Trust
 
Professor Peter Littlejohns: NICE current practice and future direction
Professor Peter Littlejohns: NICE current practice and future directionProfessor Peter Littlejohns: NICE current practice and future direction
Professor Peter Littlejohns: NICE current practice and future direction
Nuffield Trust
 

Viewers also liked (7)

Dr Jennifer Dixon: Commissioning and integrated care
Dr Jennifer Dixon: Commissioning and integrated careDr Jennifer Dixon: Commissioning and integrated care
Dr Jennifer Dixon: Commissioning and integrated care
 
Peter Smith: Allocating health care budgets to general practices
Peter Smith: Allocating health care budgets to general practicesPeter Smith: Allocating health care budgets to general practices
Peter Smith: Allocating health care budgets to general practices
 
Sara Shaw: The Trafford integration story
Sara Shaw: The Trafford integration storySara Shaw: The Trafford integration story
Sara Shaw: The Trafford integration story
 
Jo Ellins: Priority setting is everyone’s business
Jo Ellins: Priority setting is everyone’s businessJo Ellins: Priority setting is everyone’s business
Jo Ellins: Priority setting is everyone’s business
 
Professor Enthoven: Integrated delivery systems
Professor Enthoven: Integrated delivery systemsProfessor Enthoven: Integrated delivery systems
Professor Enthoven: Integrated delivery systems
 
Jennifer Dixon: Financially challenged
Jennifer Dixon: Financially challengedJennifer Dixon: Financially challenged
Jennifer Dixon: Financially challenged
 
Professor Peter Littlejohns: NICE current practice and future direction
Professor Peter Littlejohns: NICE current practice and future directionProfessor Peter Littlejohns: NICE current practice and future direction
Professor Peter Littlejohns: NICE current practice and future direction
 

Similar to Dr Jennifer Dixon: Competition between providers

John Appleby - Competition in the NHS: Good or bad (or something else)?
John Appleby - Competition in the NHS: Good or bad (or something else)?John Appleby - Competition in the NHS: Good or bad (or something else)?
John Appleby - Competition in the NHS: Good or bad (or something else)?
The King's Fund
 
Reintroductioncompetition
ReintroductioncompetitionReintroductioncompetition
Reintroductioncompetition
Socialist Health Association
 
Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS  Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS
Nuffield Trust
 
Gaynor.slides.10.22.10
Gaynor.slides.10.22.10Gaynor.slides.10.22.10
APO Korea Health System Review (Health in Transition)
APO Korea Health System Review (Health in Transition)APO Korea Health System Review (Health in Transition)
APO Korea Health System Review (Health in Transition)
Asia Pacific Observatory on Health Systems and Policies (APO)
 
MBQIP 2011 Missouri
MBQIP 2011 Missouri MBQIP 2011 Missouri
MBQIP 2011 Missouri
learfield
 
Does Regional Anesthesia have a place in Modern Perioperative Care?
Does Regional Anesthesia have a place in Modern Perioperative Care?Does Regional Anesthesia have a place in Modern Perioperative Care?
Does Regional Anesthesia have a place in Modern Perioperative Care?
Colin McCartney
 
Experiences from State Health System Development Project.ppt
Experiences from State Health System Development Project.pptExperiences from State Health System Development Project.ppt
Experiences from State Health System Development Project.ppt
suvadeepde
 
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 ThunGianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Angela Greco
 
Hugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceHugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choice
Nuffield Trust
 
Improving Quality And Reducing Cost In Healthcare The Role Of Information And...
Improving Quality And Reducing Cost In Healthcare The Role Of Information And...Improving Quality And Reducing Cost In Healthcare The Role Of Information And...
Improving Quality And Reducing Cost In Healthcare The Role Of Information And...
healthcareisi
 
Assessing the costs and effects of anti-retroviral therapy task shifting from...
Assessing the costs and effects of anti-retroviral therapy task shifting from...Assessing the costs and effects of anti-retroviral therapy task shifting from...
Assessing the costs and effects of anti-retroviral therapy task shifting from...
University of KwaZulu-Natal (UKZN) and Ethiopian Public Health Institute (EPHI)
 
Wesat2001
Wesat2001Wesat2001
Wesat2001
Mohamed Rafique
 
HFS Valera
HFS ValeraHFS Valera
HFS Valera
maivalera
 
Integrated ACO selected for the NAACOS Innovation Showcase
Integrated ACO selected for the NAACOS Innovation ShowcaseIntegrated ACO selected for the NAACOS Innovation Showcase
Integrated ACO selected for the NAACOS Innovation Showcase
Eric Weaver
 
Gaynor.slides.10.22.10
Gaynor.slides.10.22.10Gaynor.slides.10.22.10
J. pub health luisetto m, ghulam r m. research article intensive care units t...
J. pub health luisetto m, ghulam r m. research article intensive care units t...J. pub health luisetto m, ghulam r m. research article intensive care units t...
J. pub health luisetto m, ghulam r m. research article intensive care units t...
M. Luisetto Pharm.D.Spec. Pharmacology
 
health financing summit by Dr. Madz Valera
health financing summit by Dr. Madz Valerahealth financing summit by Dr. Madz Valera
health financing summit by Dr. Madz Valera
psecp
 
GH Workforce Taskshifting: Joseph Babigumira & Lou Garrison
GH Workforce Taskshifting: Joseph Babigumira & Lou GarrisonGH Workforce Taskshifting: Joseph Babigumira & Lou Garrison
GH Workforce Taskshifting: Joseph Babigumira & Lou Garrison
UWGlobalHealth
 
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US PerspectiveISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
Office of Health Economics
 

Similar to Dr Jennifer Dixon: Competition between providers (20)

John Appleby - Competition in the NHS: Good or bad (or something else)?
John Appleby - Competition in the NHS: Good or bad (or something else)?John Appleby - Competition in the NHS: Good or bad (or something else)?
John Appleby - Competition in the NHS: Good or bad (or something else)?
 
Reintroductioncompetition
ReintroductioncompetitionReintroductioncompetition
Reintroductioncompetition
 
Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS  Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS
 
Gaynor.slides.10.22.10
Gaynor.slides.10.22.10Gaynor.slides.10.22.10
Gaynor.slides.10.22.10
 
APO Korea Health System Review (Health in Transition)
APO Korea Health System Review (Health in Transition)APO Korea Health System Review (Health in Transition)
APO Korea Health System Review (Health in Transition)
 
MBQIP 2011 Missouri
MBQIP 2011 Missouri MBQIP 2011 Missouri
MBQIP 2011 Missouri
 
Does Regional Anesthesia have a place in Modern Perioperative Care?
Does Regional Anesthesia have a place in Modern Perioperative Care?Does Regional Anesthesia have a place in Modern Perioperative Care?
Does Regional Anesthesia have a place in Modern Perioperative Care?
 
Experiences from State Health System Development Project.ppt
Experiences from State Health System Development Project.pptExperiences from State Health System Development Project.ppt
Experiences from State Health System Development Project.ppt
 
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 ThunGianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
Gianfranco Domenighetti | Evidence of medical misuse in Switzerland | 2013 Thun
 
Hugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceHugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choice
 
Improving Quality And Reducing Cost In Healthcare The Role Of Information And...
Improving Quality And Reducing Cost In Healthcare The Role Of Information And...Improving Quality And Reducing Cost In Healthcare The Role Of Information And...
Improving Quality And Reducing Cost In Healthcare The Role Of Information And...
 
Assessing the costs and effects of anti-retroviral therapy task shifting from...
Assessing the costs and effects of anti-retroviral therapy task shifting from...Assessing the costs and effects of anti-retroviral therapy task shifting from...
Assessing the costs and effects of anti-retroviral therapy task shifting from...
 
Wesat2001
Wesat2001Wesat2001
Wesat2001
 
HFS Valera
HFS ValeraHFS Valera
HFS Valera
 
Integrated ACO selected for the NAACOS Innovation Showcase
Integrated ACO selected for the NAACOS Innovation ShowcaseIntegrated ACO selected for the NAACOS Innovation Showcase
Integrated ACO selected for the NAACOS Innovation Showcase
 
Gaynor.slides.10.22.10
Gaynor.slides.10.22.10Gaynor.slides.10.22.10
Gaynor.slides.10.22.10
 
J. pub health luisetto m, ghulam r m. research article intensive care units t...
J. pub health luisetto m, ghulam r m. research article intensive care units t...J. pub health luisetto m, ghulam r m. research article intensive care units t...
J. pub health luisetto m, ghulam r m. research article intensive care units t...
 
health financing summit by Dr. Madz Valera
health financing summit by Dr. Madz Valerahealth financing summit by Dr. Madz Valera
health financing summit by Dr. Madz Valera
 
GH Workforce Taskshifting: Joseph Babigumira & Lou Garrison
GH Workforce Taskshifting: Joseph Babigumira & Lou GarrisonGH Workforce Taskshifting: Joseph Babigumira & Lou Garrison
GH Workforce Taskshifting: Joseph Babigumira & Lou Garrison
 
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US PerspectiveISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
ISPOR Special Task Force on US Value Frameworks: A Non-US Perspective
 

More from Nuffield Trust

Transforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement EventTransforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement Event
Nuffield Trust
 
13 reasons to spend more on health and social care
13 reasons to spend more on health and social care 13 reasons to spend more on health and social care
13 reasons to spend more on health and social care
Nuffield Trust
 
Energising your workforce in the face of adversity
Energising your workforce in the face of adversityEnergising your workforce in the face of adversity
Energising your workforce in the face of adversity
Nuffield Trust
 
Shifting the balance of care: great expectations
Shifting the balance of care: great expectations Shifting the balance of care: great expectations
Shifting the balance of care: great expectations
Nuffield Trust
 
Automation, Employment, and Health Care
Automation, Employment, and Health Care Automation, Employment, and Health Care
Automation, Employment, and Health Care
Nuffield Trust
 
Public perspectives on the NHS and social care
Public perspectives on the NHS and social carePublic perspectives on the NHS and social care
Public perspectives on the NHS and social care
Nuffield Trust
 
Evaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers ProgrammeEvaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers Programme
Nuffield Trust
 
Ensuring success for new models of care
Ensuring success for new models of careEnsuring success for new models of care
Ensuring success for new models of care
Nuffield Trust
 
Effectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHSEffectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHS
Nuffield Trust
 
Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...
Nuffield Trust
 
Local and national uses of data
Local and national uses of dataLocal and national uses of data
Local and national uses of data
Nuffield Trust
 
Applied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillanceApplied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillance
Nuffield Trust
 
Engaging with data
Engaging with dataEngaging with data
Engaging with data
Nuffield Trust
 
Evaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitEvaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics Unit
Nuffield Trust
 
Learning from the Care Quality Commission
Learning from the Care Quality CommissionLearning from the Care Quality Commission
Learning from the Care Quality Commission
Nuffield Trust
 
Real-time monitoring and the data trap
Real-time monitoring and the data trapReal-time monitoring and the data trap
Real-time monitoring and the data trap
Nuffield Trust
 
Monitoring quality of care: making the most of data
Monitoring quality of care: making the most of dataMonitoring quality of care: making the most of data
Monitoring quality of care: making the most of data
Nuffield Trust
 
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Nuffield Trust
 
Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...
Nuffield Trust
 
New Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessonsNew Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessons
Nuffield Trust
 

More from Nuffield Trust (20)

Transforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement EventTransforming outpatient services - Nuffield Trust/NHS Improvement Event
Transforming outpatient services - Nuffield Trust/NHS Improvement Event
 
13 reasons to spend more on health and social care
13 reasons to spend more on health and social care 13 reasons to spend more on health and social care
13 reasons to spend more on health and social care
 
Energising your workforce in the face of adversity
Energising your workforce in the face of adversityEnergising your workforce in the face of adversity
Energising your workforce in the face of adversity
 
Shifting the balance of care: great expectations
Shifting the balance of care: great expectations Shifting the balance of care: great expectations
Shifting the balance of care: great expectations
 
Automation, Employment, and Health Care
Automation, Employment, and Health Care Automation, Employment, and Health Care
Automation, Employment, and Health Care
 
Public perspectives on the NHS and social care
Public perspectives on the NHS and social carePublic perspectives on the NHS and social care
Public perspectives on the NHS and social care
 
Evaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers ProgrammeEvaluation of the Integrated Care and Support Pioneers Programme
Evaluation of the Integrated Care and Support Pioneers Programme
 
Ensuring success for new models of care
Ensuring success for new models of careEnsuring success for new models of care
Ensuring success for new models of care
 
Effectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHSEffectiveness of the current dominant approach to integrated care in the NHS
Effectiveness of the current dominant approach to integrated care in the NHS
 
Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...Providing actionable healthcare analytics at scale: Understanding improvement...
Providing actionable healthcare analytics at scale: Understanding improvement...
 
Local and national uses of data
Local and national uses of dataLocal and national uses of data
Local and national uses of data
 
Applied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillanceApplied use of CUSUMs in surveillance
Applied use of CUSUMs in surveillance
 
Engaging with data
Engaging with dataEngaging with data
Engaging with data
 
Evaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics UnitEvaluating new models of care: Improvement Analytics Unit
Evaluating new models of care: Improvement Analytics Unit
 
Learning from the Care Quality Commission
Learning from the Care Quality CommissionLearning from the Care Quality Commission
Learning from the Care Quality Commission
 
Real-time monitoring and the data trap
Real-time monitoring and the data trapReal-time monitoring and the data trap
Real-time monitoring and the data trap
 
Monitoring quality of care: making the most of data
Monitoring quality of care: making the most of dataMonitoring quality of care: making the most of data
Monitoring quality of care: making the most of data
 
Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...Providing actionable healthcare analytics at scale: Insights from the Nationa...
Providing actionable healthcare analytics at scale: Insights from the Nationa...
 
Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...Providing actionable healthcare analytics at scale: A perspective from stroke...
Providing actionable healthcare analytics at scale: A perspective from stroke...
 
New Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessonsNew Models of General Practice: Practical and policy lessons
New Models of General Practice: Practical and policy lessons
 

Recently uploaded

Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 

Recently uploaded (20)

Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 

Dr Jennifer Dixon: Competition between providers

  • 1. Competition between providers: Solution, problem, or both? (necessity or nicety?) Dr Jennifer Dixon Director The Nuffield Trust 24 March 2010
  • 2. Structure  Framework  Hospital care – Independent sector activity – Choice – Impact  Primary and community care  Regulation  Where next? 2
  • 3. Framework: a lever to improve performance Target, directive, guidance Some levers to improve quality Commissioner Provider Q Local Regulation accountability E Financial incentives
  • 4. Framework: some key policies  Introduction of market-like mechanisms in NHS – 2002: independent sector clinical care encouraged – 2004: First FTs – 2003/4: payment by results (FTs) – 2004/5: payment by results (all providers) – 2006: patient choice of 4-5 providers – 2007: NHS Choices website 4
  • 5. Regulatory framework  CCP : advises on cases arising under the Principles and Rules covering:  mergers between providers of NHS services – the basis on which these should be allowed  the conduct of commissioners and service providers when it impacts on patient choice, cooperation and competition  the procurement of services by commissioners  advertising by service providers 5
  • 6. Independent sector activity  Hospital care 6
  • 7. Number of NHS-funded inpatient episodes in independent- sector healthcare providers by the month in which the episode began Source: Nuffield Trust
  • 8. Volumes of NHS-funded activity in independent sector healthcare providers (HES) 2004/5 2005/6 2006/7 2007/8 Number of inpatient episodes in 18 26 74 103 independent sector providers (000s) as percentage of all episodes 0.1% 0.2% 0.5% 0.6% Number of outpatient attendances at 18 54 268 independent sector providers (000s) as percentage of all attendances 0.0% 0.1% 0.4% Source: Nuffield Trust
  • 10. Inpatient activity of ISTCs in England (2007/8) Location of ISTC (volume indicates number of inpatient episodes) ISTC not reporting in HES 10 Source: Hospital Episode Statistics
  • 11. Use of the independent sector is limited (2007/8) The independent sector supplies 1%+ of inpatient episodes for 17% of practices The independent sector supplies 5%+ of inpatient episodes for just 2% of practices
  • 12. Practices using the independent sector the most (2007/8) General practice using the independent sector for 5%+ of inpatient episodes
  • 13. The utilisation of ISTCs and their location (2007/8) Location of ISTC (volume indicates number of inpatient episodes) ISTC not reporting in HES General practice using the independent sector for 5%+ of inpatient episodes
  • 14. Practices using the independent sector the most (2007/8) 5%+ of outpatient attendance 5%+ of inpatient episodes Source: Hospital Episode Statistics
  • 15. Summary of progress  The majority of practices in England (60%) had some independent sector provided care in 2007/8, the amounts are typically very small.  Nationally, at most 1% volume of NHS-funded acute hospital care is provided for the independent sector, even allowing for the shortcomings of the available data in HES.  NHS-funded independent sector provision of acute hospital care is relatively small and concentrated in few parts of the country.
  • 16. Choice 16
  • 17. Choices offered to patients: number of choices and whether private sector option was offered Source: Robertson R, Dixon A. Choice at the point of referral. King’s Fund
  • 18. Number of patients who were offered a choice and who attended the hospital they wanted Source: Robertson R, Dixon A. Choice at the point of referral. King’s Fund
  • 19. Number (%) of patients who were offered a choice and who attended their local hospital Source: Robertson R, Dixon A. Choice at the point of referral. King’s Fund
  • 20. Factors that influenced patients’ choice of hospital Source: Robertson R, Dixon A. Choice at the point of referral. King’s Fund
  • 21. Impact 21
  • 22. 1990 Reforms  Existing evidence on effects of competition on health outcomes in UK (England) based on ‘internal market’ of the 1990s  1990s reforms involved price competition, so incentives to drive costs down, not quality up  Competition related to purchaser choice, not patient choice  Propper et al (2004, 2008) find competition erodes quality using hospital trust data Source: Cooper Z. 22
  • 23. Health Select Committee Report 2005/6: ISTCs  No great contribution to capacity  Increased choice  No information about quality  Anecdotal impact on NHS providers from the threat of competition  Good practice and innovation but ? Relative to NHS?  Uncertainty about efficiency  Concerns about training
  • 24. Healthcare Commission report on quality of ISTCs  July 2008 and 2009: – Patients rated experience highly – Poor quality coding of data  Clinical quality cannot be assessed
  • 25. Length of stay for inpatient spells ending in 2007/8 Source: Nuffield Trust
  • 26. Death by market power? Propper C, Gaynor M, Moreno-Serra C. 2010 Does hospital competition save lives? Cooper Z, Gibbons S, Jones S, McGuire A. 2010
  • 27. Increase in competition 2003/4 to 2007/8 (actual provider HHI) Propper C, Gaynor M, Moreno-Serra C. 2010
  • 28. Increase in competition around conurbations Propper C, Gaynor M, Moreno-Serra C. 2010
  • 29. Impact of competition on outcomes and waiting times  Death rates fell more in competitive areas (note not just AMI related deaths)  Magnitude: a one standard deviation increase in competition leads to around 487 fewer AMI deaths = about 16% of mean fall 2003-2007  No change in waits or other clinical measures of outcome Propper C, Gaynor M, Moreno-Serra C. 2010
  • 30. Conclusions  Conclude: policy saved lives and did not increase costs (exact mechanism unknown)  Do not necessarily need large change in competition to bring about change  Cannot necessarily pre-judge where competitive pressures will be felt  Active merger programme would reduce competitive pressure …. Propper C, Gaynor M, Moreno-Serra C. 2010
  • 31. 95% variable GP radius 2002 and 2008 (all procedures) Cooper Z, Gibbons S, Jones S, McGuire A. 2010
  • 32. Measures of quality  Emergency admissions for Acute Myocardial Infarction (AMI – “heart attack” ICD I21 I22)  Indicator that patient died within 30 days  30 day mortality ubiquitous in the literature as a litmus/canary test of health care quality – Highly correlated with other aspects of health care quality in hospitals  General decline in death rates due to technology: e.g. angioplasty, clot-busters (and less smoking) – Scope for variable adoption of technology 32 Cooper Z, Gibbons S, Jones S, McGuire A. 2010
  • 33. Adjusted for  Patient: age, gender, ethnicity, Charlson co-morbidity score, IMD income deprivation  Procedure: day and month of admission, angioplasty, distance from GP to hospital attended  Hospital: teaching, Foundation status, number of AMIs treated per year  Hospital site dummies, Strategic Health Authority trends, GP fixed effects 33 Cooper Z, Gibbons S, Jones S, McGuire A. 2010
  • 34. Results  Robust evidence of faster rate of decline in AMI mortality post-2006 for patients from high-competition areas  One standard deviation (0.54) more competition implies about 0.3 percentage points lower probability of AMI death during 1st year of reform  Further 0.3 percentage points for each year after 2006  Results suggest no pre-policy difference in trends between high and low competition areas 34 Cooper Z, Gibbons S, Jones S, McGuire A. 2010
  • 35. Primary and community independent care 35
  • 36. Progress Fig: Primary and community care tenders per month 07-09 • Competition in primary and community care mostly involves competitive tendering • some patient choice in GP services and in some community services • The number of primary and community care tenders has been gradually increasing • Many contracts have been won by Fig: Primary and community care tenders by service the independent sector • Transforming community services Source: Quarterly Market Analysis, Local Partnerships, 2009
  • 37. Contracts awarded Contracts awarded in 2009 37 Source: Quarterly Market Analysis, Local Partnerships, 2009
  • 38. Where next?  Progress (but short term wobble)  Emerging evidence on competition good re quality (hospital only)  Prospect of mergers reducing competition  Promise of vertical integration to reduce avoidable costs  ? Competition between vertical providers or payer/providers?  How best regulated?  Evidence for public benefit test? 38